AVTX

Avalo Therapeutics Inc

Jun 15 • 04:00PM ET

14.60

-0.16 -1.08 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL RYTM INCY BMRN VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC ITOT TMSL DFAS TMED DFMC BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	8.96%	Shs Outstand	52.57M	Perf Week	14.60%
Market Cap	767.46M	Forward P/E	-	EPS next Y	-3.03	Insider Trans	-6.34%	Shs Float	47.86M	Perf Month	-23.20%
Enterprise Value	687.65M	PEG	-	EPS next Q	-0.62	Inst Own	66.40%	Short Float	13.34%	Perf Quarter	-8.86%
Income	-84.74M	P/S	12791.00	EPS this Y	47.12%	Inst Trans	21.96%	Short Ratio	4.05	Perf Half Y	-25.17%
Sales	0.06M	P/B	5.27	EPS next Y	1.73%	ROA	-71.09%	Short Interest	6.38M	Perf YTD	-19.60%
Book/sh	2.77	P/C	9.34	EPS next 5Y	20.30%	ROE	-88.76%	52W High	24.27 -39.84%	Perf Year	201.65%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	4.46 227.35%	Perf 3Y	-98.38%
Dividend Est.	0.01 (0.08%)	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	5.77% 7.36%	Perf 5Y	-99.86%
Dividend TTM	-	EV/Sales	11460.83	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.15	Perf 10Y	-99.79%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	47.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	-1.85%	Beta	0.83	Target Price	45.25
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-5.71%	Rel Volume	0.61	Prev Close	14.76
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	-5.68%	Avg Volume	1.57M	Price	14.60
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	950,291	Change	-1.08%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)